Prophylaxis of chemotherapy-induced neutropenia with Lipegfilgrastim in patients with breast cancer: results from an interim analysis of the non-interventional study NADIR

被引：0
|
作者：
Fietz, T.
Kurbacher, C. M. [1 ]
Trarbach, T. [2 ]
Salat, C.
Rezai, M. [3 ]
Lorenz, A.
Niemeier, B. [2 ]
机构：
[1] Gynakol Zentrum Bonn Friedenspl, Gynakol SP Gynakol Onkol 1, Bonn, Germany
[2] iOMEDICO AG, Freiburg, Germany
[3] Luisenkrankenhaus GmbH & Co KG, Dusseldorf, Germany
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2016年 / 39卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P952
引用
收藏
页码：293 / 293
页数：1
相关论文
共 50 条
  • [1] Prophylaxis of chemotherapy-induced neutropenia with Lipegfilgrastim in patients with lung cancer: results from an interim analysis of the non-interventional study NADIR
    Potthoff, K.
    Lueck, A.
    Frost, N.
    Losem, C.
    Weide, R.
    Schulz, H.
    [J]. ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 : 292 - 292
  • [2] Prophylaxis of chemotherapy-induced neutropenia with lipegfilgrastim in patients with breast cancer: results from an interimanalysis of the non-interventional study NADIR
    Kurbacher, C. M.
    Fietz, T.
    Trarbach, T.
    Salat, C.
    Rezai, M.
    Lorenz, A.
    Niemeier, B.
    [J]. ANNALS OF ONCOLOGY, 2016, 27
  • [3] NADIR: A Non-Interventional Study on the Prophylaxis of Chemotherapy-Induced Neutropenia Using Lipegfilgrastim - First Interim Analysis
    Kurbacher, Christian M.
    Fietz, Thomas
    Diel, Ingo J.
    Egert, Matthias
    Hurtz, Hans-Juergen
    Lueck, Andreas
    Weide, Rudolf
    Salat, Christoph
    Wolff, Thomas
    Zaiss, Matthias
    Klare, Peter
    Losem, Christoph
    Illmer, Thomas
    Weissenborn, Georg
    Steffens, Claus-Christoph
    Schulze, Matthias
    Tesch, Hans
    Oskay-Oezcelik, Guelten
    Teichmann, Beate
    Harde, Johanna
    Scheuerlein, Robert Willy
    [J]. ONCOLOGY RESEARCH AND TREATMENT, 2015, 38 (05) : 221 - 229
  • [4] Prophylaxis of chemotherapy-induced neutropenia with lipegfilgrastim in patients with lung cancer: final results from the non-interventional study NADIR
    Gessner, Christian
    Fietz, Thomas
    Losem, Christoph
    Lueck, Andreas
    Schulz, Holger
    Niemeier, Beate
    Groschek, Matthias
    Eschenburg, Henning
    Weide, Rudolf
    Kretzschmar, Albrecht
    Frost, Nikolaj
    Hipp, Joachim
    Harde, Johanna
    Matillon, Christiane D.
    Grebhardt, Sina
    Potthoff, Karin
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2022, 38 (12) : 2191 - 2199
  • [5] Prophylaxis of chemotherapy-induced neutropenia with Lipegfilgrastim in patients with SCLC: final results from the non-interventional study NADIR
    Losem, C.
    Maintz, C.
    Schulz, H.
    Lueck, A.
    Gessner, C.
    Grebhardt, S.
    Harde, J.
    Marschner, N.
    Hipp, J.
    Potthoff, K.
    [J]. ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 (SUPPL 4) : 246 - 246
  • [6] Prophylaxis of chemotherapy-induced neutropenia and febrile neutropenia with lipegfilgrastim in 2489 cancer patients: final results from the non-interventional study NADIR
    Fietz, Thomas
    Lueck, Andreas
    Schulz, Holger
    Harde, Johanna
    Losem, Christoph
    Grebhardt, Sina
    Wolff, Thomas
    Potthoff, Karin
    Mueller, Udo
    Zaiss, Matthias
    Kurbacher, Christian Martin
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2019, 35 (07) : 1127 - 1138
  • [7] Prophylaxis of chemotherapy-induced neutropenia with Lipegfilgrastim in patients with Non-Hodgkin-Lymphoma (NHL): results from an interim analysis of the non-interventional study NADIR
    Fietz, T.
    Wolff, T.
    Schulz, H.
    Sandner, R.
    Reichert, D.
    Hurtz, H. -J
    Mueller, J.
    Grebhardt, S.
    [J]. ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 : 292 - 292
  • [8] Prophylactic treatment of chemotherapy-induced neutropenia with Lipegfilgrastim in patients with breast cancer: subgroup analysis of the non-interventional study NADIR
    Kurbacher, C. M.
    Fietz, T.
    Salat, C.
    Zaiss, M.
    Gazawi, N.
    Steffens, C. -C.
    Egert, M.
    Graffunder, G.
    Papke, J.
    Weissenborn, G.
    Bueckner, U.
    Illmer, T.
    Jungberg, P.
    Lorenz, A.
    Weide, R.
    Klare, P.
    Tesch, H.
    Oskay-Oezcelik, G.
    Teichmann, B.
    Harde, J.
    Scheuerlein, R.
    [J]. ONCOLOGY RESEARCH AND TREATMENT, 2015, 38 : 77 - 78
  • [9] Prophylactic treatment of chemotherapy-induced neutropenia with Lipegfilgrastim in patients with NHL: Subgroup analysis of the non-interventional study NADIR
    Fietz, T.
    Wolff, T.
    Sandner, R.
    Janssen, J.
    Hurtz, H. -J.
    Heits, F.
    Weide, R.
    Weissenborn, G.
    Losem, C.
    Lueck, A.
    Kurbacher, C. M.
    Teichmann, B.
    Harde, J.
    Scheuerlein, R. W.
    [J]. Oncology Research and Treatment, 2015, 38 : 78 - 78
  • [10] Use of lipegfilgrastim in clinical practice for the prophylaxis of chemotherapy-induced neutropenia: interim results of pan-European non-interventional study
    Pichler, P.
    Claes, N.
    Mazza, P.
    Zurawski, B.
    Potocki, P.
    Petru, E.
    Sediva, M.
    Katolicka, J.
    Lanza, F.
    Fontaine, C.
    [J]. ANNALS OF ONCOLOGY, 2016, 27
12345